AI nearly twice as good as biopsy at assessing rare cancer

Researchers have developed an AI algorithm that is more accurate at grading the aggressiveness of a rare cancer type, retroperitoneal sarcoma.

November 1, 2023 · 1 min · 72 words · Nicole Herrera

Table of Contents

According to researchers this could save the lives of thousands of patients.

It’s free, every week, in your inbox.

Then, they tested the algorithm on a set of 89 patients across Europe and the US.

AI nearly twice as good as biopsy at assessing rare cancer

The research paper is published in the journalThe Lancet Oncology.

Story byIoanna Lykiardopoulou

Ioanna is a writer at TNW.

With a background in the humanities, she has a soft spot for social impact-enabling technologies.

Professor Christina Messiou

Ioanna Lykiardopoulou